World Bioeconomy Forum will be broadcast live from Ruka on September 10 because of Covid19

Ruka, Finland

This year’s third World Bioeconomy Forum (WCBEF) will be broadcast live from Ruka on September 10th, 2020. Due the current global pandemic the Advisory Board has decided to take a cautious approach and will provide delegates with a high-quality, interactive virtual event which will be moderated from Ruka in Finland. The event will deliver the usual high-level content, while at the same time as providing a unique experience for all bioeconomy stakeholders from around the world.

The full programme will be six hours in duration and will consist of four dedicated sessions: Regulators and Climate Change, Global Leaders and Financial World, Bioproducts around us, and Looking to the Future. The audience can contribute interactively on message walls and arrange online meetings with the other participants using the technology and channels provided. Continue reading →

Swiss Syngenta and Danish Novozymes join forces to commercialize the biofungicide Taegro

Syngenta and Novozymes are entering the commercialization phase of the biofungicide Taegro. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.

Continue reading →

Braskem is securing the supply of polypropylene polymers for the production of respiratory masks and protective medical gear

Braskem, producer of polyolefins and biopolymers, is meeting the polypropylene raw material needs of medical manufacturing customers for the production of respiratory masks as well as protective medical gear.

Continue reading →

“The bioeconomy gives us new tools and opportunities to exploit this chaotic time”. An interview with Tony Duncan, CEO Circa Group

Tony Duncan, CEO of Circa Group, at IFIB 2018 in Turin

“Within the bioeconomy we have a massive range of new tools and opportunities to exploit this chaotic time.” To say it – in this long exclusive interview with Il Bioeconomista – is Tony Duncan, CEO of Circa Group, the Australia-based biochemical company, which is revolutionizing the traditional chemical sector. With him we talk about his company and the bioeconomy in the COVID-19 age.

Interview by Mario Bonaccorso

Continue reading →

In Brussels launched an alliance for a green recovery from the Covid-19 pandemic

European Parliament, Brussels

An alliance has been launched in the European Parliament on the back of calls from 12 EU environment ministers who have signed an appeal for a green recovery from the COVID-19 pandemic. The “green recovery alliance” was launched last Monday at the initiative of Pascal Canfin, a French centrist MEP who chairs the European Parliament’s committee on environment and public health.

Continue reading →

Nouryon introduced a natural film-forming polymer for use in high SPF emulsion sunscreens

Nouryon introduced a natural film-forming polymer for use in high sun protection factor (SPF) emulsion sunscreens. SolAmaze™ Natural, which is bio-based and readily biodegradable, addresses the fast-growing consumer demand for natural and clean label ingredients in personal care products.

Continue reading →

Clariant started monthly production of 2 million liters of disinfectant using bioethanol

Hariolf Kottmann, Ceo of Clariant

Clariant, a focused and innovative specialty chemical company, today announced it has started monthly production of 2 million liters of disinfectant at its facilities in Gendorf, Germany. This disinfectant is then directly or via repacking partners provided to regional hospitals and other vital institutions in Bavaria, who are currently facing limited availability of this critical product during the COVID-19 outbreak.

Continue reading →

A Story from the Near Future

It’s awesome! The emergency is finally over. We can go back to our life. The virus was defeated without waiting for the vaccine, because we all behaved in the best way, staying at home and respecting the physical distance. Now we can go back to meet, talk to each other and, if necessary, also to hug. We’ll always remember all the dead people and the sufferings. And also the physicians and nurses and all the people who spent themselves on others.

Continue reading →

DSM completed its acquisition of Glycom to grow in the Early Life Nutrition solutions

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, completed its acquisition of Glycom A/S, the world’s leading supplier of Human Milk Oligosaccharides (HMO) for an enterprise value of €765 million.

Continue reading →

An exclusive interview with Jennifer Holmgren, CEO of LanzaTech. “We have to stop waiting for leaders to make decisions for us.  We need to act.”

Jennifer Holmgren at the Bioeconomy Investment Summit in Helsinki

“We also need to careful that the warning bells don’t go unnoticed as we try to rebuild our way of life in the same mold as before. Already we are hearing murmurings about a need for cheap (and fossil) energy to stimulate ailing virus hit sectors. We do not need to go back in time, we need to move forward. Hopefully COVID will have taught us how bad things can get when we do not think, do not plan, do not collaborate, do not listen to the science, do not listen to early warnings.  But the most important lesson, I think, is that through individual action and caring for others, people who were healthy and in “low” risk groups, stayed home. They were sacrificing for others; they were not thinking about themselves.”

To say it – in this exclusive interview with Il Bioeconomista – is Jennifer Holmgren, CEO of LanzaTech.

Interview by Mario Bonaccorso

Continue reading →